20623787

Source:http://linkedlifedata.com/resource/pubmed/id/20623787

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0023467, umls-concept:C0087111, umls-concept:C1522634
pubmed:issue	21
pubmed:dateCreated	2010-10-25
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/20623787-20629023
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0374236
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0008-543X
pubmed:author	pubmed-author:KantarjianHagopH, pubmed-author:O'BrienSusanS
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	116
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	4896-901
pubmed:meshHeading	pubmed-meshheading:20623787-Aged, pubmed-meshheading:20623787-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:20623787-Cytarabine, pubmed-meshheading:20623787-Daunorubicin, pubmed-meshheading:20623787-Humans, pubmed-meshheading:20623787-Leukemia, Myeloid, Acute, pubmed-meshheading:20623787-Middle Aged, pubmed-meshheading:20623787-Neoplasm, Residual, pubmed-meshheading:20623787-Prognosis, pubmed-meshheading:20623787-Remission Induction, pubmed-meshheading:20623787-Retreatment
pubmed:year	2010
pubmed:articleTitle	Questions regarding frontline therapy of acute myeloid leukemia.
pubmed:publicationType	Editorial, Comment, Research Support, Non-U.S. Gov't